Rel-methyl (1R,2R)-2-(hydroxymethyl)cyclopropane-1-carboxylate

Catalog No. :
ACMCQL967
CAS No. :
35501-83-8
Molecular Formula :
C6H10O3
Molecular Weight :
130.06

IUPAC Name:Rel-methyl (1R,2R)-2-(hydroxymethyl)cyclopropane-1-carboxylate

Rel-methyl (1R,2R)-2-(hydroxymethyl)cyclopropane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$181.00Login to see priceIn stockInquiry
250mg97%$331.00Login to see priceIn stockInquiry
500mg97%$332.00Login to see priceIn stockInquiry
1g97%$664.00Login to see priceIn stockInquiry
5g97%$1994.00Login to see priceIn stockInquiry
10g97%$2413.00Login to see priceIn stockInquiry
25g97%$5028.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-methyl (1R,2R)-2-(hydroxymethyl)cyclopropane-1-carboxylate
IUPAC NameRel-methyl (1R,2R)-2-(hydroxymethyl)cyclopropane-1-carboxylate
MDL No.MFCD30830129
Molecular FormulaC6H10O3
Molecular Weight130.06
SMILESCOC([C@H]1[C@@H](C1)CO)=O
InChI KeyQMFFTUAKXYCOKM-CRCLSJGQSA-N
SynonymEN300-6748601 | trans-2-Hydroxymethyl-cyclopropanecarboxylic acid methyl ester | A1-06128 | AT23910 | EN300-7102022 | SCHEMBL2955470 | rel-(1R,2R)-Methyl2-(hydroxymethyl)cyclopropanecarboxylate | Cyclopropanecarboxylic acid, 2-(hydroxymethyl)-, methyl est
CAS No.35501-83-8
PubChem CID10931461

Synthetic Route by SureRoute

1. ACMCQL967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFTLA435 route compound structure diagram
    ACFTLA43588335-97-1 In Stock
  2. Then
  3. ACMCQL967 route product structure diagram
    ACMCQL96735501-83-8 In Stock
Inquiry

2. ACMCQL967 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQNCF529 route compound structure diagram
    ACQNCF529826-35-7 In Stock
  2. Then
  3. ACMCQL967 route product structure diagram
    ACMCQL96735501-83-8 In Stock
Inquiry

Comments (0)